Incidence and Distribution of Multi-Drug Resistant Pathogens from Clinical Samples in a Tertiary Hospital in South-South Nigeria. by Iyoha, O & Tula, MY
 
 
ORIGINAL ARTICLE     
AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY.  SEPT 2014   ISBN 1595-689X VOL15 No.3 
AJCEM/1326       http://www.ajol.info/journals/ajcem 
COPYRIGHT 2014  http://dx.doi.org/10.4314/ajcam.v15i3.3                                                                                                                                                                                                                                            
AFR. J. CLN. EXPER. MICROBIOL. 15(3): 130-137 
 
INCIDENCE AND DISTRIBUTION OF MULTI-DRUG RESISTANT PATHOGENS FROM 
CLINICAL SAMPLES IN A TERTIARY HOSPITAL IN SOUTH-SOUTH NIGERIA. 
1*Iyoha, O. and Tula, M.Y. 
1*Department of Medical Microbiology, School of Medicine, College of Medical Science, University of Benin, P.M.B. 1152, 
Benin City, Nigeria ; 2Department of Biological Science Technology, Federal Polytechnic Mubi, P.M.B. 35, Adamawa 
State,Nigeria. 
*Correspondence :. E-mail: drosaiyoha@yahoo.co.uk. Tel: +2348023352188 
ABSTRACT 
Background  
Antibiotics have proven to be a dynamic category of drugs in the fight against infectious bacteria. However, antibiotic 
resistance is one of the greatest current challenges to the effective treatment of infections and there is every indication that 
antibiotic resistance will become an even greater challenge in the future.                                                                              
Methodology                                                                                                                                                                                                        
Ten clinical samples with varying frequencies were analyzed for bacterial growth, antibiotic susceptibility testing and 
multiple antibiotic resistances. The clinical samples includes; urine (42%), wound swab (21.33%), blood (10%), ear swab 
(9.33%), catheter tip (5.33%), endocervical swab (4.67%), high vaginal swab (HVS) (2.67%), urethral swab (2.67%), pus 
(1.33%) and antral aspirate (0.67%).                                                                                                                      
Results                                                                                                                                                                                     
A total of 150 bacterial isolates distributed among these ten (10) clinical samples were identified, of which Staphylococcus 
aureus (30%) was the most predominant, while Klebsiella oxytoca, Citrobacter spp. and Streptococcus spp. were the least 
(0.67%). These were tested for sensitivity against 9 antibiotics. The resistance rate observed was as follows; cefuroxime 
(93%), ceftazidime (87%), gentamycin (79%), augmentin (70%), cloxacillin (67%), ofloxacin (54%), ciprofloxacin (51%), 
ceftriaxone (38%) and ocefix (34%). One hundred and forty-three (95.3%) of the isolates showed multiple resistance against 
3 – 8 antibiotics. None was resistant to as few as 1 – 2 antibiotics.                                                                                                         
Conclusion                                                                                                                                                                                                      
The high susceptibility to some antibiotics such as ceftriaxone and ocefix could be a welcoming relief, since they can be 
used to address the problem of resistance in this area. There is need for nationwide surveillance programme to monitor 
microbial trends and antimicrobial resistance patterns in Nigeria.  
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Contexte 
Les antibiotiques se sont démontrés être une catégorie dynamique des médicaments pour lutter contre les infections 
bactériennes. Cependant, la résistance aux antibiotiques est l’un des grands défis actuels pour le traitement efficace des 
infections et tout porte à croire que la résistance aux antibiotiques devient un défi encore plus grand à l’avenir.  
Méthodologie 
Dix échantillons cliniques avec leurs grandes fréquences ont été analysés par la culture bactériennes, le teste de sensibilité 
aux antibiotiques et le teste de la multirésistance aux antibiotiques. Les échantillons cliniques sont constitués de l’urine 
(42%), de pus de la plaie (21,33%), de sang (10%), de prélèvement d’oreille (9,33%), d’extrémité du cathéter (5,33%), de 
prélèvement d’endocervical (4,67%), de prélèvement vaginal (2,67%), de prélèvement urétral (2,67%), de pus (1,33%), de 
ponctionantrale(0,67%). 
Résultats 
Au total, 150 souches bactériennes réparties parmi les dix (10) échantillons cliniques ont été identifiées, parmi lesquelles 
Staphylococcus aureus (30%) était le plus prédominant, alors que Klebsiellaoxytoca,Citrobacterspp etStreptococcusspp 




suivant: céfuroxime (93%), ceftazidime (87%), gentamicine (79%), augmentin (70%), cloxacilline (67%), ofloxacine (54%), 
ciprofloxacine (51%), ceftriaxone (38%) etocefix (34%). Cent-quarante-trois (95,3%)  d’isolats ont montré la multi-résistance 
contre 3 à 8 antibiotiques. Aucune souche n’a été résistante à moins de 1 à 2 antibiotiques. 
Conclusion 
La forte sensibilité de certains antibiotiques tels que la ceftriaxone et l’ocefix pourraient être un ouf de soulagement, car ils 
peuvent être utilisés pour résoudre le problème de la résistance dans cette région. Il est nécessaire pour le programme 
national de surveillance pour suivre les tendances microbiennes et les situations de résistance aux antimicrobiens au 
Nigeria. 




Antimicrobial resistance is a well known clinical 
and public health problem [1]. Over the last 60yrs, 
bacteria in particular, those pathogenic for humans 
have evolved toward antimicrobial drug resistance. 
This evolution has 2 key steps; emergence and 
dissemination of resistance [2]. Antimicrobial 
resistance in nosocomial infections is increasing 
with both morbidity and mortality greater than 
when infection is caused by drug sensitive 
organisms. These infections are opportunistic and 
microorganisms of low virulence can cause diseases 
in hospitalized patients whose immune 
mechanisms are impaired. The outcome is that 
many antibiotics can no longer be used for the 
treatment of infections caused by such organisms 
and the threat to the usage of other drugs increases 
[3, 4].  
The widespread use of broad- spectrum antibiotics, 
immunocompromised patients, and exogenous 
transmission of bacteria, usually by hospital 
personnel has led to the emergence of nosocomial 
infections caused by drug resistant microbes [5, 6]. 
Available therapeutic options for antibiotic resistant 
organisms are severely limited, as these organisms 
frequently display a multi-drug resistant phenotype 
[7, 8, and 6]. Multi-drug resistance (MDR) and the 
presence of several virulence factors in the strains of 
many pathogens responsible for different diseases 
pose an increasing threat to the successful 
management of disease scourge [9]. However, 
strategies for addressing antimicrobial drug 
resistance stress the need for new drug [10] and yet 
the rate of drug development is in decline [11, 12]. 
 Several investigators revealed that the most 
frequently reported bacterial pathogens from 
clinical sources with multi-drug resistance have 
been E. coli, S. aureus, P. aeruginosa, K. pneumoniae, 
Proteus spp., Acinetobacter spp., Enterococcus spp., 
coagulase negative staphylococci (CONS), etc.[13, 
14, 15 and 16]. 
As the proliferation of multi-drug resistance 
pathogens continue unavoidably in the hospital 
settings, within and around us, it is imperative that 
their resistance trend be put under check through 
intensive research and antibiotic surveillance. 
Therefore, this current study reports on the 
incidence and distribution of multi-drug resistant 
bacteria pathogens from clinical samples in a 
tertiary hospital in south-south Nigeria. 
 
MATERIAL AND METHODS 
Sample collections 
One hundred and fifty clinical samples classified 
into ten groups were obtained from routine section 
in Medical Microbiology Laboratory of University 
of Benin Teaching Hospital (UBTH), Benin City, 
Nigeria. The sources of the samples were as follows: 
urine (42%), wound swab (21.33%), blood (10%), ear 
swab (9.33%), catheter tip (5.33%), endocervical 
swab (4.67%), high vaginal swab (2.67%), urethral 
swab (2.67%), pus (1.33%), and antral aspirate 
(0.67%). The samples were analysed for bacterial 
growth within 1-2 hrs after collection. 
Identification of bacterial isolates 
All the samples were plated on Blood agar, 
MacConkey agar and replicated on Mannitol salt 
agar (oxoid, England). The inoculated plates were 
incubated at 37°C for 24h. Identification of bacterial 
isolates was done on the basis of their cultural and 
standard biochemical characteristics. [17]. The 
isolates were sub-cultured on nutrient agar slants 
periodically to maintain pure culture. 
Antibiotic Susceptibility Testing 
Isolates were tested for antimicrobial susceptibility 
testing by the standard disc diffusion method. 
Standard inoculums adjusted to 0.5 McFarland was 
swabbed on Mueller Hinton agar and was allowed 
to soak for 2 to 5 minutes. After that the appropriate 
antibiotic disc were aseptically placed on the agar 
surface using sterile forceps and the plates were 
incubated at 370C for 24hrs. Commercially available 
antimicrobial discs used included: ciprofloxacin 
(30g), ceftriaxone (10g), ofloxacin (25g), 
augmentin (25g), cefuroxime (30g), gentamycin 
(10g), ceftazidime (30g), cloxacillin (10), and 
ocefix (10g). The degree of susceptibility of the test 
isolates to each antibiotic was interpreted as either 
sensitive (S) or resistant (R) according to National 





The Chi-square goodness of fit test was used to test 
for significant differences in the data obtained. All 
statistical analyses were carried out using the SPSS 
17.0 window based program. Significance 
difference and non- significance difference was 





Figure 1 showed the sources of 10 clinical samples 
used in the study. Urine (42%) was the most 
predominant clinical sample, followed by wound 
swab (21.3%) and blood (10%); while the least 
clinical sample was antral aspirate (0.7%), closely 
followed by pus (1.3%) and HVS (2.7%).  
The isolates were confirmed as Staphylococcus 
aureus, Klebsiella pneumoniae, Escherichia coli, 
Pseudomonas aeruginosa, Proteus mirabilis, coagulase 
negative staphylococci (CoNS), Citrobacter spp., 
Alcaligenes spp., Enterobacter spp., Klebsiella oxytoca 
and Streptococcus spp. Of these isolates, 57(38%) 
were Gram positive and 93(62%) were Gram 
negative. Staphylococcus aureus was the most 
common Gram positive isolates (79%), while 
Klebsiella pneumoniae was the most common Gram 
negative isolates (31%). Staphylococcus aureus 
45(30%) was the most predominant isolate, 
followed by Klebsiella pneumoniae 28(18.7%), while 
Citrobacter spp., Klebsiella oxytoca and Streptococcus 
spp. were the least with 1(0.7%) each (Table I). 
Staphylococcus aureus had their highest occurrence 
from urine samples. Pseudomonas aeruginosa had its 
highest incidence in wound swab, while Klebsiella 
pneumoniae was the most common organism 
isolated from catheter tip and blood. The result also 
showed that Staphylococcus aureus and CoNS were 
the most predominant organisms in endocervical 
swab, while S. aureus and P. aeruginosa were the 
most occurring isolates from ear swab.  
 
Figure 1: Percentage incidence of clinical samples. 
                        Key: ECS = Endocervical swab, HVS = high vagina swab 





SA EC KP KO CONS PA PM CS AS ES SS 
Urine 21(46.67) 15(57.69) 12(42.85) - 4(36.36) - 4(33.33) - 6(75) 1(50) - 
WS 6(13.33) 7(26.92) 2(7.14) - - 11(73.33) 3(25) - 2(25) 1(50) - 
US 4(8.89) - - - - - - - - - - 
CT - - 6(21.43) - - - 2(16.67) - - - - 
Blood 4(8.89) 2(7.69) 5(17.86) 1(100) 1(9.09) - 1(8.33) 1(100) - - - 
ECS 3(6.67) - 1(3.57) - 3(27.27) - - - - - - 
Ear 
swab 
4(8.89) - 2(7.14) - 2(18.18) 4(26.67) 2(16.67) - - - - 
HVS 1(2.22) 2(7.69) - - - - - - - - 1(100) 
Pus 2(4.44) - - - - - - - - - - 
AS - - - - 1(9.09) - - - - - - 
Total 45(30) 26(17.33) 28(18.67) 1(0.67) 11(7.33) 15(10) 12(8) 1(0.67) 8(5.33) 2(1.33) 1(0.67) 
KEY: SA = Staphylococcus aureus, EC: Escherichia coli,   KP = Klebsiella pneumoniae,   KO = Klebsiella oxytoca,   CONS = Coagulase negative Staphylococcus                     
PA = Pseudomonas aeruginosa,   PM= Proteus mirabilis,    CS = Citrobacter spp.,   AS = Alcaligens spp.,   ES = Enterobacter spp.,   SS = Streptococcus spp., WS = 
Wound swab, US = Urethral swab,   CT = catheter tip,   ECS = Endocervical swab,   HVS = High vagina swab,   AS = Antral aspirate 
Table II showed the antibiogram of the isolates. 
Resistance by all the isolates to cefuroxime was the 
highest (92.7%), followed by ceftazidime (86.7%), 
gentamycin (79.3%), augmentin (70%), cloxacillin 
(66.7%), ofloxacin (54%) and ciprofloxacin (51.3%). 

























TABLE II: ANTIBIOGRAM OF ISOLATES (%) 
Antibiotics No.sensitive No.resistance  
Ciprofloxacin 73(48.7) 77(51.3) 
Ceftriaxone 93(62) 57(38) 
Ofloxacin 69(46) 81(54) 
Augmentin 44(29) 106(70) 
Cefuroxime 11(7.3) 139(92.7) 
Gentamycin 31(20.7) 119(79.3) 
Ceftazidime 20(13.3) 130(86.7) 
Cloxacillin 50(33.3) 100(66.7) 
Ocefix 99(66) 51(34) 
 
against cefuroxime by all the isolates were not 
significantly different from that of ceftazidime and 
gentamycin > 	, but were significantly 
higher than other antibiotics < 	.  Similarly, 
resistance against ocefix by all the isolates were not 
significantly different from that of ceftriaxone and 
ciprofloxacin > 	, but were significantly 
lower than that of other antibiotics  < 	 The 
result further showed significant correlation 
between cefuroxime and ceftazidime < 1	. 
TABLE III: NO. OF ORGANISMS WITH MULTIPLE 







0 0 1 
0 0 2 
7 4.7 3 
21 14.0 4 
29 19.3 5 
40 26.7 6 
39 26.0 7 
14 9.3 8 
150 100  
 
Of the 150 isolates obtained, 143(95.3%) of them 
were multi-drug resistant. Seven(4.7%) of the 
isolates were resistant to 3 antibiotics, 21(14%) were 
resistant to 4 antibiotics, and 29(19.3%) were 
resistant to 5 antibiotics. While 40(26.7%), 39(26%), 
and 14(9.3%) of the isolates were resistant to 6, 7, 
and 8 antibiotics respectively. Ninety three (62%) of 




The result of this study shows that the most 
predominant clinical sample was urine.  This result 
was in conformity with the works of some 
researchers who in their studies also reported that 
urine was the most common clinical sample 
encountered [13, 19 and 20]. 
 The observation in this study that Staphylococcus 
aureus was the predominant organism from 
nosocomial samples examined is in support with 
reports from other researchers [21, 22, 23, 24 and 
25]. It however contradicts reports from some 
researchers who reported other organisms to be 
most predominant. Such organisms include E. coli 
[26, 27 and 20], Klebsiella pneumoniae [19], and 
Staphylococcus epidermidis [6]. The high incidence of 
S. aureus in this study could be as a result of its 
minimal growth requirements, ability to survive 
long in most unfavorable environments and in a 
susceptible host. It could also be due to the virulent 
nature of the organism, which gives it the ability to 
overcome body defense mechanisms and resistance 
to antibiotics [24]. Urinary tract instrumentation 
and presence of indwelling catheter increase the 
risk of S. aureus carriage in the urinary tract [28]. 
The finding in this study that Pseudomonas 
aeruginosa had its highest occurrence in wound 
swab is contrary to the findings of Mordi and 
momoh [25] who reported that S. aureus was the 
most predominant organism in wound swabs.  
The observation in this work that K. pneumoniae was 
the most predominant organism from catheter tips 
and blood is contrary to Iffat et al [20], who reported 
S. aureus to be the most predominant isolate 
instead. Their report that the most predominant 
isolate from pus was E. coli is also contrary to the 
observation in this study which revealed S. aureus 
to be the predominant organism from pus   
The most predominant Gram negative organism 
isolated in this study was K. pneumoniae. This result 
disagrees with that of some researchers who 
reported E. coli to be the predominant Gram 
negative organisms in their samples [20, 26 and 27]. 
Also, Mordi and Momoh, [25] reported that Proteus 
spp. was the most predominant Gram negative 
isolate in their study. Variations in the types of 
organisms isolated could be attributed to factors 
such as environmental difference, media, culturing 
method, time and method of sampling. Period of 
transportation and storage before culturing can also 
be causative factors. 
The result of this study revealed very high 




(92.7%). This result is contrary to the findings of 
Yah and Eghafona [29], who reported very low 
resistance of their diarrhoeal isolates towards 
cefuroxime. It however, agrees with the work of 
Adeleke et al. [30], who reported high resistance 
towards cefuroxime (81.8%) by Gram negative 
organisms. Their reported high resistance against 
ceftriaxone however contradicts the observation in 
this study in which very low resistance to same 
antibiotic was observed. Iffat et al. [20], in their 
work reported high resistance rate among Gram 
negative organisms against all generations of 
cephalosporin antibiotics as well as β-lactam/β-
lactamase inhibitors. This study in contrast 
observed low resistance rate towards ceftriaxone 
(38%) and ocefix (34%), both of which are 
cephalosporins. 
The contrasting antibacterial activity of ceftriaxone 
(38% resistance) and cefuroxime (92.7% resistance) 
in this study agrees with the previous reports of a 
better activity for ceftriaxone than cefuroxime [31, 
32 and 33]. Nevertheless, the equally contrasting 
multiple drug resistance against cefuroxime, 
ceftazidime, ceftriaxone and ocefix (all 
cephalosporins) confirm the alarm raised by Paul et 
al.[34], on the alarming rate of resistance to 
cephalosporins by the hospital strains especially 
Gram negative bacteria and more so with the 
advent of the extended spectrum β-lactamases 
producers [35, 36]. This confirms a report that in 
Nigeria, β-lactams are the most frequently 
prescribed antibiotics especially in Gram negative 
infections and selective pressure exerted by the use 
of these β-lactam drugs have resulted in the strains 
producing the extended spectrum β-lactamases 
enzymes [37].  
The result of this study further showed that all the 
isolates were highly resistant against gentamycin 
(79.3%), augmentin (70%), cloxacillin (66.7%), 
ofloxacin (54%), and ciprofloxacin (51.3%).  Similar 
resistance patterns were reported by other workers 
[19, 26]. High resistance toward ciprofloxacin by 
Klebsiella pneumoniae and low resistance against 
ciprofloxacin by CoNS and Pseudomonas aeruginosa 
as observed in this study had also been reported by 
Iffat et al. [20].    
Almost all the pathogens isolated in this study have 
also been shown to cause different forms of 
nosocomial infections [7, 8, 38, 39, and 40]. S. aureus 
exhibits remarkable versatility in their behaviour 
towards antibiotics [41]. Outbreaks of S. aureus 
resistant to β-lactam antibiotics have been 
frequently associated with devastating nosocomial 
infections [6, 42 and 43]. 
Klebsiella pneumoniae (and some related species) is 
an important opportunistic Gram-negative rod 
pathogen involved in the outbreaks of nosocomial 
infections, meningitis, lower respiratory, urinary 
tract and burn wound infections. The members of 
this genus have also been linked to epidemics of 
diarrhea, because some strains appear to have 
acquired plasmids from E. coli (that code for the 
heat labile and heat stable enterotoxins [44, 45]. 
Pseudomonas aeruginosa is a ubiquitous organism, an 
opportunistic pathogen, and can cause a wide range 
of infections including bacterial meningitis, 
endocarditis, Otitis media [46] urinary tract 
infection [47] and osteomyelitis [48]. Pseudomonas 
aeruginosa is notorious for its resistance to 
antibiotics and is therefore, a particularly 
dangerous and dreaded pathogen. The bacterium is 
naturally resistance to many antibiotics due to the 
permeability barrier afforded by its outer 
membrane lipopolysaccharide (LPS). Also, its 
tendency to colonize surfaces in a biofilm form 
makes the cells impervious to therapeutic 
concentrations of antibiotics [49]. 
Escherichia coli is an important opportunistic 
pathogen that has shown an increasing 
antimicrobial resistance to most antibiotics [50, 51]. 
Intestinal strains of E. coli are primary cause of 
urinary tract infections, septicaemia, diarrhoea, 
neonatal meningitis and nosocomial infections. 
Individuals who are debilitated or have other 
predisposing factors are at much risk for infection 
than healthy person [52]. Antibiotic resistance was 
high among E. coli strains, which emphasize the 
need for judicious use of antibiotics. Certain 
virulence factors like hemolysin production and 
presence of fimbriae in the strain may be associated 
with its virulence especially urovirulence [53]. 
Coagulase negative staphylococci (CoNS) especially 
Staphylococcus epidermidis is a major cause of 
nosocomial infections because of its ability to form 
biofilms on the surface of medical devices. Bacterial 
biofilms are inherently resistant to antibiotics and 
host defences, and this could explain the reason for 
the high resistance seen in the strains isolated in 
this study [6, 54, and 55]. 
Eight (8) strains of Alcaligenes spp., were isolated in 
this study, and were 100% resistant to cefuroxime, 
augmentin and ceftazidime. The strains were also 
highly resistance to ofloxacin, gentamycin and 
ciprofloxacin. Alcaligenes spp. is generally 
considered non-pathogenic but can occur as an 
opportunistic pathogen in urinary tract infection 
[56]. Some species of Alcaligenes are potential causes 
of chronic pulmonary diseases in patients with 
cystic fibrosis [57]. 
High rates of drug resistance were found in most of 
the isolates studied. In developing countries like 
Nigeria, self medication is a common practice and 
this might probably be a major cause of antibiotic 
resistance in clinical isolates since patients only 




to treat themselves. On admission, the community 
acquired resistant strains exchange genetic material 
with nosocomial isolates resulting in the emergence 
of ‘superbugs’ that could cause difficult to treat 
infections [6, 58]. Inappropriate practice like misuse 
and abuse of antibiotics and unskilled practitioners 
can also lead to emergence of resistance in bacteria. 
Expired antibiotics, counterfeit drugs, inadequate 
hospital infection control measures can as well 
promote the development of resistance in clinical 
isolates [6, 59].  
 
Conclusion  
It is apparent from the results of the antibiogram 
that hospitals could be a potential reservoir of 
nosocomial antibiotic resistant pathogens. The high 
incidence of antibiotic resistant strains isolated from 
clinical samples of patients in University of Benin 
Teaching Hospital (UBTH) is worrisome, and need 
to be addressed properly. We highly recommend 
the development of infection control programmes 
for the surveillance of nosocomial infections and 
epidemiologic typing of clinical isolates in hospitals 
in order to check the emergence and spread of 
antibiotic resistant infections in patient.   
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